Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
15.48
-0.14 (-0.90%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Sotera Health Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Revenue | 1,098 | 1,049 | 1,004 | 931.48 | 818.16 | 778.33 | Upgrade
|
Revenue Growth (YoY) | 12.50% | 4.54% | 7.75% | 13.85% | 5.12% | 4.31% | Upgrade
|
Cost of Revenue | 492.21 | 472.13 | 446.68 | 412.81 | 374.59 | 381.8 | Upgrade
|
Gross Profit | 605.97 | 577.16 | 557 | 518.67 | 443.57 | 396.53 | Upgrade
|
Selling, General & Admin | 167.48 | 159.56 | 166.18 | 149.36 | 136.6 | 132.06 | Upgrade
|
Operating Expenses | 230.1 | 223.35 | 229.12 | 213.14 | 195.63 | 190.62 | Upgrade
|
Operating Income | 375.87 | 353.8 | 327.89 | 305.53 | 247.94 | 205.91 | Upgrade
|
Interest Expense | -165.44 | -142.88 | -80.14 | -74.19 | -215.26 | -157.73 | Upgrade
|
Currency Exchange Gain (Loss) | 1.84 | -0.16 | -0.15 | -1.35 | 5.23 | -3.86 | Upgrade
|
Other Non Operating Income (Expenses) | -0.2 | 2.38 | -0.46 | 3.56 | 4.16 | 3.04 | Upgrade
|
EBT Excluding Unusual Items | 212.07 | 213.15 | 247.14 | 233.55 | 42.07 | 47.36 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | - | -6.89 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | -9.61 | - | - | - | Upgrade
|
Legal Settlements | -95.68 | -107.12 | -480.64 | -45.66 | -36.67 | -11.22 | Upgrade
|
Other Unusual Items | -24.09 | - | - | -15.58 | -44.26 | -30.17 | Upgrade
|
Pretax Income | 92.3 | 106.03 | -243.11 | 175.72 | -38.86 | -0.92 | Upgrade
|
Income Tax Expense | 52.2 | 54.65 | -9.54 | 58.6 | -1.37 | 19.51 | Upgrade
|
Earnings From Continuing Operations | 40.1 | 51.38 | -233.57 | 117.12 | -37.49 | -20.43 | Upgrade
|
Minority Interest in Earnings | - | - | - | -0.24 | -1.13 | -0.43 | Upgrade
|
Net Income | 40.1 | 51.38 | -233.57 | 116.88 | -38.62 | -20.85 | Upgrade
|
Preferred Dividends & Other Adjustments | 0.16 | 0.29 | - | 1.52 | - | - | Upgrade
|
Net Income to Common | 39.94 | 51.09 | -233.57 | 115.36 | -38.62 | -20.85 | Upgrade
|
Shares Outstanding (Basic) | 282 | 281 | 280 | 279 | 238 | 232 | Upgrade
|
Shares Outstanding (Diluted) | 284 | 283 | 280 | 279 | 238 | 232 | Upgrade
|
Shares Change (YoY) | 1.18% | 1.12% | 0.26% | 17.54% | 2.28% | -0.00% | Upgrade
|
EPS (Basic) | 0.14 | 0.18 | -0.83 | 0.41 | -0.16 | -0.09 | Upgrade
|
EPS (Diluted) | 0.14 | 0.18 | -0.83 | 0.41 | -0.16 | -0.09 | Upgrade
|
Free Cash Flow | 32.31 | -362.71 | 95.58 | 179.38 | 67.08 | 91.78 | Upgrade
|
Free Cash Flow Per Share | 0.11 | -1.28 | 0.34 | 0.64 | 0.28 | 0.39 | Upgrade
|
Gross Margin | 55.18% | 55.00% | 55.50% | 55.68% | 54.22% | 50.95% | Upgrade
|
Operating Margin | 34.23% | 33.72% | 32.67% | 32.80% | 30.30% | 26.46% | Upgrade
|
Profit Margin | 3.64% | 4.87% | -23.27% | 12.38% | -4.72% | -2.68% | Upgrade
|
Free Cash Flow Margin | 2.94% | -34.57% | 9.52% | 19.26% | 8.20% | 11.79% | Upgrade
|
EBITDA | 537.6 | 514.14 | 475.63 | 458.68 | 393.5 | 354.68 | Upgrade
|
EBITDA Margin | 48.95% | 49.00% | 47.39% | 49.24% | 48.10% | 45.57% | Upgrade
|
D&A For EBITDA | 161.72 | 160.34 | 147.75 | 153.15 | 145.56 | 148.77 | Upgrade
|
EBIT | 375.87 | 353.8 | 327.89 | 305.53 | 247.94 | 205.91 | Upgrade
|
EBIT Margin | 34.23% | 33.72% | 32.67% | 32.80% | 30.30% | 26.46% | Upgrade
|
Effective Tax Rate | 56.55% | 51.54% | - | 33.35% | - | - | Upgrade
|
Revenue as Reported | 1,098 | 1,049 | 1,004 | 931.48 | 818.16 | 778.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.